Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel diseaseBram Verstockt, Marc Ferrante, Sare Verstockt et al.|EBioMedicine|2019Cited by 173
Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel DiseaseSare Verstockt, Séverine Vermeire, Bram Verstockt et al.|Inflammatory Bowel Diseases|2021Cited by 84
Expression Levels of 4 Genes in Colon Tissue Might Be Used to Predict Which Patients Will Enter Endoscopic Remission After Vedolizumab Therapy for Inflammatory Bowel DiseasesBram Verstockt, Marc Ferrante, Sare Verstockt et al.|Clinical Gastroenterology and Hepatology|2019Cited by 77
Mucosal IL13RA2 expression predicts nonresponse to anti‐TNF therapy in Crohn's diseaseBram Verstockt, Christine Breynaert, Sare Verstockt et al.|Alimentary Pharmacology & Therapeutics|2019Cited by 72
Oncostatin M as a new diagnostic, prognostic and therapeutic target in inflammatory bowel disease (IBD)Sare Verstockt, Séverine Vermeire, Bram Verstockt|Expert Opinion on Therapeutic Targets|2019Cited by 57